Literature DB >> 10360809

Increase of HIV-1 subtype A in Central African Republic.

M C Müller-Trutwin1, M L Chaix, F Letourneur, E Bégaud, D Beaumont, A Deslandres, B You, J Morvan, C Mathiot, F Barré-Sinoussi, S Saragosti.   

Abstract

The concomitant presence of five distinct HIV-1 subtypes and of unclassified HIV-1 was reported in Bangui, Central African Republic (C.A.R.) between 1990 and 1991. This previous study was conducted in individuals belonging to the C.A.R. Armed Forces (FACA) Cohort and in patients from the University Hospital of Baugui. To follow the HIV-1 subtype distribution in Bangui over time, we conducted a cross-sectional surveillance of HIV-1 subtypes between 1987 and 1997 in three groups of individuals in Bangui: 47 men belonging to the FACA Cohort, 38 patients from the CNHUB hospital, and 51 individuals consulting the sexually transmitted diseases (STD) clinic. One hundred and ten HIV-1 were subtyped by heteroduplex mobility assay (HMA) and/or sequencing of env regions encompassing the V3 domain. By comparing the HIV-1 distribution in two time periods (1987-1991 and 1991-1996) in the FACA cohort, we observed a significant increase of subtype A from 43.7% to 83.9%. This subtype distribution does not seem specific to the FACA cohort, in that subtype A accounted for 46.7% of the HIV-1 infections in CNHUB patients in the first time period studied and for 69.6% in the second time period. In STD patients, subtype A infections were predominant in 1995 (72.7%) and 1997 (89.7%). Subtype E viruses could be identified in the second time period, but represented only between 6.5% and 21.8% of the infections in the three groups of individuals studied. Other subtypes (B, C, H) and non-classified HIV-1 in C2-V3 were detected with only a 3.2% to 9.1% frequency for each in the second time period. Phylogenetic analysis excluded infection by a single source for the individuals included in the study. Our data demonstrate an increase in the proportion of HIV-1 subtype A infections in Bangui that raises the question of a preferential transmissibility of specific HIV-1 variants.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10360809

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  10 in total

1.  Identification and genetic characterization of a novel CRF22_01A1 recombinant form of HIV type 1 in Cameroon.

Authors:  Jiangqin Zhao; Shixing Tang; Viswanath Ragupathy; Jean K Carr; Nathan D Wolfe; Bih Awazi; Indira Hewlett
Journal:  AIDS Res Hum Retroviruses       Date:  2010-09       Impact factor: 2.205

2.  Phylodynamics of the HIV-1 CRF02_AG clade in Cameroon.

Authors:  Nuno R Faria; Marc A Suchard; Ana Abecasis; João D Sousa; Nicaise Ndembi; Idalina Bonfim; Ricardo J Camacho; Anne-Mieke Vandamme; Philippe Lemey
Journal:  Infect Genet Evol       Date:  2011-05-04       Impact factor: 3.342

3.  Unprecedented degree of human immunodeficiency virus type 1 (HIV-1) group M genetic diversity in the Democratic Republic of Congo suggests that the HIV-1 pandemic originated in Central Africa.

Authors:  N Vidal; M Peeters; C Mulanga-Kabeya; N Nzilambi; D Robertson; W Ilunga; H Sema; K Tshimanga; B Bongo; E Delaporte
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

4.  Impact of viral factors on very early in vivo replication profiles in simian immunodeficiency virus SIVagm-infected African green monkeys.

Authors:  Ivona Pandrea; Christopher Kornfeld; Mickael J-Y Ploquin; Cristian Apetrei; Abdourahmane Faye; Pierre Rouquet; Pierre Roques; François Simon; Françoise Barré-Sinoussi; Michaela C Müller-Trutwin; Ousmane M Diop
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

5.  Positive regulation of CXCR4 expression and signaling by interleukin-7 in CD4+ mature thymocytes correlates with their capacity to favor human immunodeficiency X4 virus replication.

Authors:  Nathalie Schmitt; Laurent Chêne; David Boutolleau; Marie-Thérèse Nugeyre; Eric Guillemard; Pierre Versmisse; Catherine Jacquemot; Françoise Barré-Sinoussi; Nicole Israël
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

Review 6.  Evolution and diversity of HIV-1 in Africa--a review.

Authors:  Maria A Papathanasopoulos; Gillian M Hunt; Caroline T Tiemessen
Journal:  Virus Genes       Date:  2003       Impact factor: 2.332

7.  Predominance of HIV-1 subtype A and D infections in Uganda.

Authors:  D J Hu; J Baggs; R G Downing; D Pieniazek; J Dorn; C Fridlund; B Biryahwaho; S D Sempala; M A Rayfield; T J Dondero; R Lal
Journal:  Emerg Infect Dis       Date:  2000 Nov-Dec       Impact factor: 6.883

8.  Reduced CD4 T cell activation and in vitro susceptibility to HIV-1 infection in exposed uninfected Central Africans.

Authors:  Evélyne Bégaud; Loïc Chartier; Valéry Marechal; Julienne Ipero; Josianne Léal; Pierre Versmisse; Guillaume Breton; Arnaud Fontanet; Corinne Capoulade-Metay; Hervé Fleury; Françoise Barré-Sinoussi; Daniel Scott-Algara; Gianfranco Pancino
Journal:  Retrovirology       Date:  2006-06-22       Impact factor: 4.602

9.  HIV-1 clade D is associated with increased rates of CD4 decline in a Kenyan cohort.

Authors:  Lyle R McKinnon; Nico J Nagelkerke; Rupert Kaul; Souradet Y Shaw; Rupert Capina; Ma Luo; Anthony Kariri; Winnie Apidi; Makobu Kimani; Charles Wachihi; Walter Jaoko; A Omu Anzala; Joshua Kimani; T Blake Ball; Francis A Plummer
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

10.  Phylodynamic applications in 21st century global infectious disease research.

Authors:  Brittany D Rife; Carla Mavian; Xinguang Chen; Massimo Ciccozzi; Marco Salemi; Jae Min; Mattia Cf Prosperi
Journal:  Glob Health Res Policy       Date:  2017-05-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.